PLAIN ANSWERS FROM THE STUDIES
What the Studies Can and Can't Answer
Each answer names who or what was tested, what happened, and what remains unknown about CJC-1295 and Ipamorelin.
Has CJC-1295 with Ipamorelin helped people?
Researchers haven't run a fair human trial of the fixed CJC-1295 and Ipamorelin pair. Cells in a dish and tests in healthy men found a larger growth-hormone burst when two different messages reached the growth gland [5][7]. That helps explain why CJC-1295 is paired with Ipamorelin. It doesn't show a better result for your health.
A 2026 review combined five well-run trials of tesamorelin, a related peptide. People lost liver fat and deep belly fat, gained lean weight, and had more IGF-1, a growth protein made by the liver [1]. Those findings belong to tesamorelin, not CJC-1295 or the fixed pair. No fair test has shown a health gain from the pair [2]. This site doesn't advise using it.
What bad effects may come with CJC-1295 or Ipamorelin?
Growth hormone may leave extra water in your body. You may also face sore joints, tingling like carpal tunnel, and higher blood sugar [2]. A shot may leave your skin red or sore. One 28-day rat study found more heart-muscle harm as animals got more of a related drug [13]. That wasn't either peptide, so the finding warns about the wider drug group but proves no harm from either one.
Researchers haven't tested the red face, swelling, tiredness, or faint feeling described by people who tried the pair for research, and their amounts and sources aren't known. Neither peptide has a long human safety trial [2]. That missing work matters when you weigh a claim for your health.
How soon did CJC-1295 change the blood tests?
One peptide stays in blood far longer than the other. CJC-1295 with DAC—the form with a blood-protein hook—began raising growth hormone within hours of a shot under the skin. The rise lasted 6 or more days. IGF-1 stayed high for 9 to 11 days or more, and up to 28 days after more shots [3].
In its human blood study, Ipamorelin went into a vein. One growth-hormone burst was highest near 40 minutes, and half the drug left in about 2 hours [15]. No fair human study says whether repeat use makes you feel different in days or weeks. The pair's IGF-1 change isn't known, so you won't find a timing plan here.
Did a study set a CJC-1295 dose for the pair?
No fair trial has set a human dose for the fixed pair. This site doesn't provide one. Published amounts belong only to their own tests. Healthy adults received 30 to 60 micrograms for each kilogram of body weight of CJC-1295 [3]. In the bowel-surgery trial, patients received 0.03 milligrams for each kilogram of body weight of Ipamorelin through a vein [14].
Those figures aren't a plan for you. The people were watched under study rules, and no test used the fixed pair. A licensed doctor who knows your medical history can answer a question about your care.
What is CJC-1295 made to do?
CJC-1295 is a lab-made copy of the brain's message for releasing growth hormone. It uses 29 amino acids, which your body also uses to build proteins. Four are changed so blood clears the drug more slowly. The DAC form has a hook that bonds to albumin, a common blood protein. That can stretch its time in blood from minutes to days [4].
A 2025 medical review covers CJC-1295 and related peptides such as sermorelin and tesamorelin [8]. It says the group can change hormone readings, while many hoped-for uses remain unproved. CJC-1295 isn't approved medicine. A lab found it in a seized, unlabeled vial with a very exact chemical test [9]. That doesn't make any unmarked supply safe for you.
CJC-1295 changed blood tests, not proven health
CJC-1295 prompts the growth gland beneath your brain, which puts growth hormone in your bloodstream and tells your liver to make IGF-1. In healthy adults, one shot under the skin raised average growth hormone for six or more days. IGF-1 rose for 9 to 11 days. After more shots, IGF-1 stayed high for up to 28 days [3].
Normal hormone bursts kept coming, but the reading between bursts didn't fall as low [11]. That is how the bursts could stay normal while the low level rose. Another blood study found several proteins rising or falling after CJC-1295. Some changed as IGF-1 changed [10]. I read these CJC-1295 tests as blood changes, not proof that people felt better or that you would benefit.
Short studies can't prove CJC-1295 is safe
No. People often tolerated CJC-1295 during the short blood studies [3][11]. That can't prove safety over months or years. A broad review names higher blood sugar from weaker insulin as the main worry for this kind of drug [2]. CJC-1295 keeps growth hormone and IGF-1 high for days.
In 2024, a group that advises FDA about drugs mixed by local pharmacies also raised concerns about immune reactions, heart effects, impurities, and unwanted pieces left from making the peptide [9]. No large human safety trial or years-long CJC-1295 study exists. Your own doctor can weigh those gaps against your health. This site can't make that call.
Did CJC-1295 studies prove a treatment dose?
No dose is proved for treating people, and you won't find one here. A CJC-1295 blood study in healthy adults used 30 or 60 micrograms for each kilogram of body weight under the skin [3]. Those are study facts, not advice for you.
No approved use or fair trial has shown both a health gain and safety at a set amount. Online plans from people using the drug for research don't come from fair human trials [2]. A licensed doctor can consider your health and the missing proof together.
What is Ipamorelin made to do?
Ipamorelin is a lab-made peptide, a small string of amino acids. It copies part of ghrelin, the hormone that helps bring on hunger. Growth-gland cells also read that message and release growth hormone. CJC-1295 copies another message, so the two can work together [5][6].
Ipamorelin isn't approved medicine. Its only published Phase 2 trial—an early human check for benefit and short-term harm—had 114 bowel-surgery patients and missed its main test [14]. WADA, the world sport drug-testing body, bans it under Section S2, its growth-hormone rule. Keep that failed human trial in view when judging a claim.
Has Ipamorelin been shown to help people?
No fair trial has shown a health gain from Ipamorelin. In rats and pigs, it released growth hormone without much rise in cortisol, the body's stress hormone, prolactin, which helps make breast milk, or one other hormone, even above 200 times the needed amount [6]. In one human study, a hormone burst was highest near 40 minutes. Half the drug left in about 2 hours [15].
Repeated amounts made adult female rats' bones grow faster without a change in IGF-1. Blood signs of bone being built or worn down didn't change either [16]. A Phase 2 human trial—an early benefit check—didn't clearly shorten the time to a first meal after bowel surgery [14]. People using Ipamorelin for research report better sleep and recovery, but no fair trial has checked those claims.
Selective means it changed fewer hormones in early tests
Ipamorelin was called selective because its early effect was narrow. It released growth hormone without raising cortisol, the stress hormone, or one other hormone. An older peptide called GHRP-6 raised more hormones; GHRP means growth-hormone-releasing peptide [6].
Five amino acids make up Ipamorelin, and some are changed so your blood doesn't cut the drug apart as fast. The drug copies part of ghrelin, your natural hunger hormone. Human blood facts come from studies that put Ipamorelin into a vein [15]. They don't show how an injection beneath your skin moves through your blood.
Blood sugar, cancer, and heart risks remain open
Growth hormone can make insulin work less well. The liver-made growth protein helps cells grow, which raises concern about a hidden cancer [2]. A 28-day study found more heart-muscle harm as rats got more of a related drug [13]. That drug wasn't Ipamorelin. The result warns about the wider drug group but doesn't prove harm from Ipamorelin.
In cells taken from the body, Ipamorelin made pancreas cells release insulin. It also helped mice form fat without growth hormone [2]. Long human safety facts don't exist. The only fair human trial was a 7-day study using a vein [14]. A research supply may not meet medicine-making rules. Those gaps matter even though your exact risk isn't known.